
Please try another search
BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. The company offers a substance use disorder recovery program, Beat Addiction Recovery, which includes cognitive behavioral therapy modules, peer support through a mobile application, and medication prescription from an independent treating physician; and the UnCraveRx weight loss program, a medication-assisted weight loss program that includes access to concierge on-demand wellness specialists. It also develops BICX101, an injectable and implantable naltrexone product; BICX102, a long-acting naltrexone implant that can last several months for opioid dependence and alcohol use disorders; and BICX104, a biodegradable, long-acting subcutaneous pellet of naltrexone for the treatment of alcohol and opioid use disorder. The company licenses and distributes its program to healthcare providers and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. was founded in 2009 and is based in Anaheim, California.
Name | Age | Since | Title |
---|---|---|---|
Lourdes Felix | 57 | 2012 | CEO, CFO & Director |
Kent Emry | 57 | 2013 | Independent Director |
Ben Gil Price | 69 | 2014 | Member of Advisory Board |
Mark Sorrentino | - | 2014 | Member of Advisory Board |
Louis Charles Lucido | 77 | 2019 | President & Director |
David R. Gastfriend | - | 2019 | Member of Scientific Advisory Board |
Richard Haatvedt | - | 2014 | Member of Advisory Board |
Luisa Ingargiola | 57 | 2019 | Independent Director |
Priya S. Jambhekar | - | 2021 | Member of Scientific Advisory Board |
Evgeny M. Krupitsky | - | 2019 | Member of Scientific Advisory Board |
Jeff Witkin | - | 2021 | Member of Scientific Advisory Board |
George E. Woody | - | 2019 | Member of Scientific Advisory Board |
Michael Howcroft | - | 2021 | Member of Scientific Advisory Board |
Joseph John Galligan | 66 | 2021 | Independent Director |
Ashok Kumar | - | 2021 | Member of Scientific Advisory Board |
Jie Shen | - | 2021 | Member of Scientific Advisory Board |
Kate Beebe DeVarney | - | 2024 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review